SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited is a fully integrated, commercial-stage specialty pharmaceutical company with therapeutic focus on oncology/hematology, infectious diseases, and neurodegenerative diseases. SymBio has been committed to moving forward into unexplored underserved therapeutic areas where urgent and unmet medical needs exist since its establishment in 2005. Our experts with extensive experience in drug discovery and evaluation globally navigate through information about new drugs from bio-ventures, laboratories, and pharmaceutical companies, selecting with discerning capacity the most promising drug candidates that are likely to meet compelling medical needs. Our Scientific Advisory Board (SAB) is comprised of leading clinicians and scientists who provide impartial screening of potential drug candidates before they are brought into our pipeline.